Results 201 to 210 of about 885,457 (308)

In Vivo Cytoskeletal AMPA Receptor Transport Imaging in C. elegans

Cytoskeleton, EarlyView.
ABSTRACT Long‐distance intracellular transport of ionotropic glutamate receptors (iGluRs) is essential for proper excitatory synaptic function underlying learning and memory. Many neuropsychiatric and neurodegenerative conditions have abnormal iGluR transport and trafficking, leading to an intense interest in the mechanisms and factors regulating these
Michaelis A. K., Hoerndli F. J.
wiley   +1 more source

Editorial: Celebrating the 20th Anniversary of Pakistan Journal of Analytical & Environmental Chemistry

, 2020
Najma Memon
openalex   +1 more source

Streamlined spectrofluorimetric assay for Pramipexole using acid red 87 quenching strategy for tablet and uniformity evaluation. [PDF]

Sci Rep
Abu-Hassan AA.
europepmc   +1 more source

A Phase 1, Randomized, Open‐Label, Parallel Group Study to Evaluate the Relative Bioavailability and Safety of Subcutaneous Bepirovirsen when Delivered from a Vial or Prefilled Syringe Fitted with a Safety Syringe Device in Healthy Adult Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef, Poonam Shah, Maxwell Hu, Helene Plein, Abhishek Roy, Ravi Sharma, Sarah Mole, Magdalena Blazejczyk, Wendy Cross, Brian Spears, Samuel Pak, Rejbinder Kaur, Robert Elston, Dickens Theodore, Marjan Hezareh, Ahmed Nader   +15 more
wiley   +1 more source

Artificial Intelligence as a Scientific Copilot in Analytical Chemistry: Transforming How We Write, Review, and Publish. [PDF]

Anal Chem
Fuente-Ballesteros A, Samanidou V, Daryanavard SM, Ares AM, Bernal J.   +4 more
europepmc   +1 more source

A Phase 1 Open‐Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Zavegepant is the only calcitonin gene‐related peptide antagonist approved as a nasal spray in the United States for acute treatment of migraine in adults with or without aura. This Phase 1, open‐label study evaluated the pharmacokinetics, safety, and tolerability of a single intranasal dose of zavegepant 10 mg in 12 healthy Chinese adults ...
Qiong Wei, Jufang Wu, Yangyi Dai, Jiaye Lin, Beikang Ge, Yanhui Sun, Jing Zhang, Jing Wang, Chen Li, Ding Ding, Jing Liu, Mohamed H. Shahin   +11 more
wiley   +1 more source

Journal of Environmental Analytical Chemistry [PDF]

, 2019
openaire   +1 more source

International Journal of Environmental Analytical Chemistry

, 2011
Walter Ignácio Gonçalves dos Santos, Dannuza Dias Cavalcante, Hadla S. Ferreira, Cesário Francisco das Virgens, Aline Rocha Borges, Silva, Márcia Siqueira de Carvalho, Andresa Lourenço da, Maria Carla Bulhão de Queirós Andrade VALE, Walter Ignácio Gonçalves dos Santos, Dannuza Dias Cavalcante, Hadla S. Ferreira, Cesário Francisco das Virgens, Aline Rocha Borges, Silva, Márcia Siqueira de Carvalho, Andresa Lourenço da, Maria Carla Bulhão de Queirós Andrade VALE   +13 more
openalex   +1 more source

Eco-conscious AQbD-guided stability-indicating RP-UPLC method for analysing Tovorafenib in bulk and dosage forms. [PDF]

Sci Rep
Goud VM, Bukke SPN, Kusuma PK, Rani SS, Reddy MS, Thalluri C, Narapureddy BR.   +6 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis

Clinical Pharmacology &Therapeutics, EarlyView.
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis   +5 more
wiley   +1 more source